Carl Dambkowski, Chief Medical Officer at Apogee Therapeutics, Inc. (APGE), sold 13,330 shares at $46.07 ($614K) on 2024-12-04, disclosed to the SEC on 2024-12-06.
Scheduled sale ($614k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.07 | 6,665 | $307K | 50.0% |
| 2 | $46.07 | 6,665 | $307K | 50.0% |
| Total | $46.07 avg | 13,330 | $614K | 100% |
| Filing → |
| ORKA | SELL | 2026-06-12 | $2.5M | — | Filing → |
| APGE | SELL | 2026-06-05 | $433K | — | Filing → |
| ORKA | SELL | 2026-05-22 | $6.2M | — | Filing → |